Comparison of Two HIV Postexposure Prophylaxis Regimens Among Men Who Have Sex With Men in Amsterdam: Adverse Effects Do Not Influence Compliance
- 1 November 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Sexually Transmitted Diseases
- Vol. 37 (11), 681-686
- https://doi.org/10.1097/olq.0b013e3181e2f999
Abstract
To compare 2 regimens for HIV postexposure prophylaxis (PEP) as to safety, adherence, outcome, and follow-up in men who have sex with men (MSM) in Amsterdam. Since 2000, all MSM starting HIV PEP in Amsterdam have been followed in 1 location. The regimen was comprised of zidovudine or lamivudine and nelfinavir (regimen 1) until 2005, when nelfinavir was replaced by atazanavir (regimen 2). All patient data, including data on PEP side effects and testing for alanine aminotransferase (ALT), were systematically recorded and compared between the 2 regimens from 2000 to 2007. HIV PEP was prescribed 309 times to MSM. Of the 261 who were followed up, 237 (91%) completed their 28-day course. Although fewer patients had diarrhea on regimen 2 than on regimen 1 (P = 0.00), the proportion completing either course was the same: 98 of 110 (89%) and 139 of 151 (92%), respectively (P = 0.42). Only 1 patient with severely elevated ALT was advised to stop PEP, he also had serious illness. MSM at least 30 years of age and MSM who had sex with a partner known to be HIV-positive completed their course significantly more often than those under 30 and those who had sex with a partner of unknown HIV status (P < 0.005). Of MSM who completed PEP, 5 seroconverted for HIV despite good adherence to PEP. None of their viruses were resistant to the PEP regimen used. No difference in adherence was found between the 2 regimens, even though fewer adverse effects were reported on regimen 2. ALT need not be routinely tested to monitor adverse effects. The 5 seroconversions were not likely caused by PEP failure, but rather by ongoing HIV exposures.Keywords
This publication has 16 references indexed in Scilit:
- Trends in Hepatitis A, B, and Shigellosis Compared With Gonorrhea and Syphilis in Men Who Have Sex With Men in Amsterdam, 1992–2006Sexually Transmitted Diseases, 2008
- Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention interventionAIDS Care, 2008
- Trends in HIV Postexposure Prophylaxis Prescription and Compliance After Sexual Exposure in Amsterdam, 2000–2004Sexually Transmitted Diseases, 2007
- Postexposure prophylaxis after sexual exposure to HIVCurrent Opinion in Infectious Diseases, 2007
- HIV Postexposure Prophylaxis in Sexual Assault: Current Practice and Patient Adherence to Treatment Recommendations in a Large Urban Teaching HospitalAcademic Emergency Medicine, 2005
- Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm?Sexually Transmitted Infections, 2005
- The use of a triple nucleoside‐nucleotide regimen for nonoccupational HIV post‐exposure prophylaxisHIV Medicine, 2005
- Postexposure Prophylaxis After Sexual Assaults: A Prospective Cohort StudySexually Transmitted Diseases, 2005
- Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP StudyThe Journal of Infectious Diseases, 2001
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureNew England Journal of Medicine, 1997